HDL in atherosclerosis: actor or bystander?

BF Asztalos, EJ Schaefer - Atherosclerosis Supplements, 2003 - Elsevier
Despite dramatic improvement in treatments for reducing risk for coronary heart disease
(CHD), it is still the leading cause of mortality in the developed world. In the past decade, a …
被引用次数：102 相关文章

HDL in atherosclerosis: actor or bystander?

BF Asztalos, EJ Schaefer - Atherosclerosis (Supplements)(Component), 2003 - infona.pl
Despite dramatic improvement in treatments for reducing risk for coronary heart disease
(CHD), it is still the leading cause of mortality in the developed world. In the past decade, a …

HDL in atherosclerosis: actor or bystander?

BF Asztalos, EJ Schaefer - Atherosclerosis, Supplements, 2003 - elibrary.ru
Despite dramatic improvement in treatments for reducing risk for coronary heart disease
(CHD), it is still the leading cause of mortality in the developed world. In the past decade, a …

HDL in atherosclerosis: actor or bystander?

BF Asztalos, EJ Schaefer - Atherosclerosis. Supplements, 2003 - europepmc.org
Despite dramatic improvement in treatments for reducing risk for coronary heart disease
(CHD), it is still the leading cause of mortality in the developed world. In the past decade, a …

HDL in atherosclerosis: actor or bystander?

BF Asztalos, EJ Schaefer - Atherosclerosis. Supplements, 2003 - pubmed.ncbi.nlm.nih.gov
Despite dramatic improvement in treatments for reducing risk for coronary heart disease
(CHD), it is still the leading cause of mortality in the developed world. In the past decade, a …

[引用][C] HDL in atherosclerosis: actor or bystander?

BF ASZTALOS, EJ SCHAEFER - Atherosclerosis. Supplement, 2003 - Elsevier